(JAAD Submission) Dermatology residents combined oral contraceptive pill prescribing practices, supplemental data

Combined oral contraceptive pills (COCs) are a safe and effective FDA approved adjunct therapy for females with acne vulgaris. However, data is lacking assessing U.S. dermatology residents’ use of COCs. Our cross-sectional survey study of dermatology residents aimed to identify prescribing practices, knowledge, and comfort level utilizing COCs for treatment of acne vulgaris. The Institutional Review Board of Penn State/ Hershey Medical Center approved the study protocol. An anonymous survey was emailed to ACGME approved U.S. dermatology residency program coordinators and directors to forward to their residents. Responses were analyzed with descriptive statistics highlighting areas for improvement. Stored here is supplemental data including demographics and knowledge of medication interactions.

复方口服避孕药（Combined Oral Contraceptive Pills, COCs）是经美国食品药品监督管理局（Food and Drug Administration, FDA）批准的、用于治疗寻常痤疮女性患者的安全有效辅助治疗方案。然而，目前尚缺乏针对美国皮肤科住院医师使用复方口服避孕药情况的评估数据。本研究针对皮肤科住院医师开展横断面调查，旨在明确其使用复方口服避孕药治疗寻常痤疮的处方行为、认知水平及应用熟练度。宾夕法尼亚州立大学/赫尔希医疗中心机构审查委员会（Institutional Review Board）批准了本研究的试验方案。我们将匿名调查问卷通过电子邮件发送给获得美国毕业后医学教育认证委员会（Accreditation Council for Graduate Medical Education, ACGME）认证的美国皮肤科住院医师培训项目协调员与主任，委托其转发给所属住院医师。研究采用描述性统计方法对回收的问卷结果进行分析，梳理出亟需改进的方向。本数据集包含补充数据，涵盖受试者人口统计学信息以及药物相互作用相关认知情况。